There’s more to dna than just the double helix we know and love: under some conditions this familiar molecule can take on ...

A new wave of biomimetic ingredients is reshaping skincare, tapping into the skin’s own repair and defence systems to deliver ...

Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with standard-of-care ...

Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself inside living human cells and can be programmed to stop propagation of harmful ...

This local biotech says it has found a way to trick cancer cells into destroying themselves with its molecular glue. Now it’s putting that claim to the test. After attracting global attention from ...

Antioxidants have been marketed as miracle supplements, touted for preventing chronic diseases and cancers; treating COPD and ...

Neomorph begins human testing of a molecular glue therapy that selectively removes cancer-driving proteins, targeting clear cell renal cell carcinoma.

Dr. Kennedy joins Aprea at an important time, following the Company’s recent early clinical proof-of-concept demonstrated in its ongoing Phase 1 dose-escalation study evaluating the WEE1 inhibitor APR ...

Research from NeuroQure, a biotechnology company specializing in autism spectrum disorder, has led to the development of a ...

Every year, malaria kills more than 600,000 people worldwide. Most of them are children under 5 in sub-Saharan Africa. But the disease isn’t confined to poor, rural areas – it’s a global threat that ...

UNSW researchers have helped design a simple, wearable patch to give clinicians up-to-the-minute readouts of a medication's ...